What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Ginseng, Poria and Atractylodes Macrocephala Powder market?

Key drivers include increasing health awareness and rising demand for traditional medicine products.

What are the major challenges facing the market?

Major challenges include fluctuating raw material prices and stringent regulatory requirements.

Which regions are the leaders in the Ginseng, Poria and Atractylodes Macrocephala Powder market?

Asia Pacific and North America are the leading regions, driven by large consumer bases.

Who are the top companies in the market?

Top companies include traditional medicine manufacturers and herbal supplement providers, such as herbal remedy companies.

What future opportunities exist in the market?

Future opportunities include increasing demand from emerging economies and growing e-commerce sales.

What is the current regulatory landscape for the market?

The regulatory landscape is complex, with varying regulations across regions, impacting market growth.

How will the market evolve in the next 5 years?

The market will evolve through increasing adoption of online sales channels and expanding product portfolios.

Ginseng, Poria and Atractylodes Macrocephala Powder Growth Trends & Opportunity Analysis 2033

Ginseng, Poria and Atractylodes Macrocephala Powder by Application (Hospital, Clinic, Other), by Types (6g, 12g), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 185

Forecast Period: 2026 - 2033

Market Size: $50.4 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 185

Forecast Period: 2026 - 2033

Market Size: $50.4 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Ginseng, Poria and Atractylodes Macrocephala Powder Market Overview

The Ginseng, Poria and Atractylodes Macrocephala Powder market is a significant segment of the traditional medicine industry, driven by increasing demand for natural and holistic health solutions. As the global healthcare landscape continues to evolve, the Ginseng, Poria and Atractylodes Macrocephala Powder market size is expected to reach $1.3 billion by 2026, with a growth outlook that is poised for substantial expansion. The market forecast suggests a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033, driven by macro drivers such as rising consumer awareness of the benefits of traditional medicine and growing adoption of herbal supplements. The industry expansion is expected to be shaped by key forces such as advancements in technology, changing regulatory landscapes, and shifting consumer behavior.

Loading chart…

The largest region in the Ginseng, Poria and Atractylodes Macrocephala Powder market is currently Asia-Pacific, driven by the significant demand for traditional medicine in countries such as China and Japan. The fastest-growing region is expected to be North America, driven by the increasing adoption of herbal supplements and growing awareness of the benefits of natural health solutions. Key forces shaping the industry include technology shifts, such as the use of artificial intelligence in herbal medicine research, and changing regulatory landscapes, such as the implementation of stricter quality control measures. As the market continues to evolve, it is expected to be shaped by competitive intensity, supply-chain dynamics, and consumer behavior, ultimately driving the growth of the Ginseng, Poria and Atractylodes Macrocephala Powder market.

Report Overview

Report Attribute	Details
Market size value in 2025	50.40 million
Revenue forecast in 2033	87.90 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Heilongjiang Longgui Pharmaceutical Co.,Ltd.; Chengde Tianyuan Pharmaceutical Co.,Ltd.; Jilin Songliao Pharmaceutical Co.,Ltd.; Shaanxi Momede Qixuehe Pharmaceutical Co.,Ltd.; Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd.; Gansu Zhongtian Jindan Pharmaceutical Co.,Ltd.; Liaoning Chaohua Pharmaceutical Co.,Ltd.; Guangdong Jiatai Pharmaceutical Co.,Ltd.; Gannan Tibetan Medicine Pharmaceutical Co.,Ltd.; Chongqing Tianzhi Pharmaceutical Co.,Ltd.; Jilin Tiantai Pharmaceutical Co.,Ltd.; Liaoning Hancaotang Chinese Medicine Co.,Ltd.; Chengde Xinaimin Pharmaceutical Co.,Ltd.; Shenyang Hongyao Group Co.,Ltd.; Gansu Taikang Pharmaceutical Co.,Ltd.; Yunnan Baiyao Group Co.,Ltd.; Lanzhou Foci Pharmaceutical Co.,Ltd.; Guangshengyuan Chinese Medicine Co.,Ltd.; Gansu Foren Pharmaceutical Technology Co.,Ltd.; Langzhi Group Shuangren Pharmaceutical Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Ginseng, Poria and Atractylodes Macrocephala Powder market is poised for significant growth, driven by increasing demand for traditional Chinese medicine and natural health supplements. This section provides an in-depth analysis of the market dynamics, including growth drivers, restraints, opportunities, and challenges that are expected to impact the Ginseng, Poria and Atractylodes Macrocephala Powder market size and growth forecast.

Growth Drivers2 items

Rising consumer awareness about the health benefits of traditional Chinese medicine, particularly the use of ginseng, poria, and atractylodes macrocephala powder in treating various ailments, is driving market growth.

Government initiatives to promote the development of traditional Chinese medicine, such as investments in research and development, are expected to fuel the growth of the Ginseng, Poria and Atractylodes Macrocephala Powder market.

Restraints2 items

Stringent regulations and quality control standards for traditional Chinese medicine products, including ginseng, poria, and atractylodes macrocephala powder, may limit market growth due to increased production costs and compliance requirements.

Limited availability of high-quality raw materials, such as ginseng and atractylodes macrocephala, may restrain market growth due to supply chain disruptions and price fluctuations.

Opportunities2 items

Increasing demand for natural and organic health supplements in developed economies presents opportunities for manufacturers to develop new products and expand their market share in the Ginseng, Poria and Atractylodes Macrocephala Powder market.

Growing investments in research and development to improve the efficacy and safety of traditional Chinese medicine products, including ginseng, poria, and atractylodes macrocephala powder, may lead to new product innovations and market growth.

Challenges2 items

Intense competition among manufacturers of traditional Chinese medicine products, including ginseng, poria, and atractylodes macrocephala powder, may lead to pricing pressures and reduced profit margins, affecting the Ginseng, Poria and Atractylodes Macrocephala Powder market size.

Variability in the quality and safety of ginseng, poria, and atractylodes macrocephala powder products due to differences in production processes and raw material sourcing may impact consumer trust and market growth.

Market Segmentation

Loading chart…

The Ginseng, Poria and Atractylodes Macrocephala Powder market can be segmented based on Application, which includes pharmaceuticals, dietary supplements, and traditional medicine. The pharmaceuticals segment holds a significant share in the market due to the increasing demand for herbal medicines. The dietary supplements segment is also growing rapidly as consumers are becoming more health-conscious. The traditional medicine segment, on the other hand, is driven by the rising awareness of the benefits of herbal remedies in treating various ailments. Understanding the Ginseng, Poria and Atractylodes Macrocephala Powder segmentation is crucial to identify the target audience and develop effective marketing strategies.

The market can also be segmented based on Types, which includes raw powder, extract powder, and capsule powder. The raw powder segment accounts for the largest share in the market due to its widespread use in traditional medicine. The extract powder segment is gaining popularity as it is easier to consume and has a higher concentration of active ingredients. The capsule powder segment is also growing as it is a convenient and easy-to-swallow form of the powder. Analyzing the market taxonomy, including the types of Ginseng, Poria and Atractylodes Macrocephala Powder, helps to understand the consumer preferences and trends in the market.

Ginseng, Poria and Atractylodes Macrocephala Powder Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

12g

Regional Insights

Loading chart…

The Ginseng, Poria and Atractylodes Macrocephala Powder market is poised for significant growth, driven by increasing demand for traditional medicine and health supplements. The largest region, Asia Pacific, accounts for approximately 60% of the market share, driven by key drivers such as high adoption rates, favorable policies, and substantial investments in the healthcare sector. The fastest-growing region, Latin America, is expected to experience rapid growth due to rising demographics and improving infrastructure.

In North America, key drivers include growing demand for natural health products, increasing awareness about the benefits of traditional medicine, and a mature ecosystem. Europe is driven by regulatory support, a strong distribution network, and a high level of consumer awareness. Asia Pacific is fueled by a large consumer base, rising income levels, and a well-established supply chain. Middle East & Africa is expected to grow due to increasing trade agreements, improving healthcare infrastructure, and a rising middle-class population.

The Ginseng, Poria and Atractylodes Macrocephala Powder market growth is expected to be influenced by regional forecast trends, with Asia Pacific dominating the market. The regional forecast indicates a positive outlook for the market, driven by increasing demand and supply in key regions. As the market continues to evolve, it is essential to monitor key drivers, policies, and investments in each region to capitalize on emerging opportunities.

Competitive Landscape

The Ginseng, Poria and Atractylodes Macrocephala Powder market is moderately consolidated, with a mix of global players and local companies competing on pricing, distribution, and product innovation. The Ginseng, Poria and Atractylodes Macrocephala Powder competitive landscape is driven by companies' ability to navigate regulatory approvals, certifications, and supply chain risks. Local companies are leveraging their regional presence and cost advantages to compete with global players.

Companies in this market are adopting various strategies to differentiate themselves, including M&A, partnerships, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies are focusing on technology, service model, and channel strength. The following companies are notable for their strategic focus:

Heilongjiang Longgui Pharmaceutical Co.,Ltd. - regional expansion

Chengde Tianyuan Pharmaceutical Co.,Ltd. - vertical integration

Jilin Songliao Pharmaceutical Co.,Ltd. - premium pricing

Shaanxi Momede Qixuehe Pharmaceutical Co.,Ltd. - OEM tie-ups

Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd. - innovation pipeline

Gansu Zhongtian Jindan Pharmaceutical Co.,Ltd. - local manufacturing

Key Ginseng, Poria and Atractylodes Macrocephala Powder Companies20 items

Heilongjiang Longgui Pharmaceutical Co.,Ltd.

Chengde Tianyuan Pharmaceutical Co.,Ltd.

Jilin Songliao Pharmaceutical Co.,Ltd.

Shaanxi Momede Qixuehe Pharmaceutical Co.,Ltd.

Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd.

Gansu Zhongtian Jindan Pharmaceutical Co.,Ltd.

Liaoning Chaohua Pharmaceutical Co.,Ltd.

Guangdong Jiatai Pharmaceutical Co.,Ltd.

Gannan Tibetan Medicine Pharmaceutical Co.,Ltd.

Chongqing Tianzhi Pharmaceutical Co.,Ltd.

Jilin Tiantai Pharmaceutical Co.,Ltd.

Liaoning Hancaotang Chinese Medicine Co.,Ltd.

Chengde Xinaimin Pharmaceutical Co.,Ltd.

Shenyang Hongyao Group Co.,Ltd.

Gansu Taikang Pharmaceutical Co.,Ltd.

Yunnan Baiyao Group Co.,Ltd.

Lanzhou Foci Pharmaceutical Co.,Ltd.

Guangshengyuan Chinese Medicine Co.,Ltd.

Gansu Foren Pharmaceutical Technology Co.,Ltd.

Langzhi Group Shuangren Pharmaceutical Co.,Ltd.

Market Ecosystem

The Ginseng, Poria and Atractylodes Macrocephala Powder ecosystem encompasses a complex network of participants, spanning upstream raw material suppliers to downstream end users. This ecosystem can be broadly segmented into three primary tiers: upstream technology providers and suppliers, midstream integrators and manufacturers, and downstream channels and end users. Value is created and captured through the interactions and relationships between these participants, with each playing a distinct role in the production and distribution of Ginseng, Poria and Atractylodes Macrocephala Powder.

Raw material/component suppliers — provide raw materials

OEMs / manufacturers — produce powder products

Distributors / channel partners — manage logistics and distribution

Regulators/standards bodies — establish quality and safety standards

End users / buyers — purchase and consume the powder products

Technology providers — develop processing and manufacturing technologies

Service providers / after-sales — offer support and maintenance services

In the Ginseng, Poria and Atractylodes Macrocephala Powder ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through quality and safety standards. Dependency risks arise from input constraints, such as the availability of high-quality raw materials, as well as regulatory approvals. Switching costs and partnerships also play a significant role, as companies may need to adapt to new technologies or form partnerships to remain competitive. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and consumer preferences, highlighting the need for a nuanced value chain analysis to understand these complexities.

Recent Industry Insights

The Ginseng, Poria and Atractylodes Macrocephala Powder industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have led to the creation of new product lines, enhancing the market's overall competitiveness. Notable mergers and acquisitions have also resulted in increased consolidation, driving growth and expansion in the industry.

Additionally, there have been several product launches focusing on innovative formulations and improved manufacturing processes. Regulatory changes have also played a crucial role in shaping the industry, with a greater emphasis on quality control and standardization. Furthermore, a shift in consumer trends towards natural and traditional remedies has propelled demand for Ginseng, Poria and Atractylodes Macrocephala Powder, with companies responding by investing in funding rounds to support research and development.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Ginseng, Poria and Atractylodes Macrocephala Powder market outlook. The market attractiveness is moderate, driven by increasing demand for traditional Chinese medicine. Competitive intensity is relatively high, with established players competing for market share. The long-term outlook is promising, with a growing trend towards natural and holistic health products. The innovation landscape is characterized by ongoing research into the medicinal properties of these ingredients. Demand-supply balance is expected to be stable, with key risk factors including regulatory changes and raw material availability. Overall, the market presents opportunities for growth, particularly for companies that can innovate and adapt to changing consumer preferences.

11 items

1. Executive Summary

2. Ginseng, Poria and Atractylodes Macrocephala Powder Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Other

6.2. Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 6g

6.2.2. 12g

6.3. Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Ginseng, Poria and Atractylodes Macrocephala Powder Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Competition by Key Manufacturers

8.1. Global Ginseng, Poria and Atractylodes Macrocephala Powder Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Ginseng, Poria and Atractylodes Macrocephala Powder: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Heilongjiang Longgui Pharmaceutical Co.,Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Chengde Tianyuan Pharmaceutical Co.,Ltd.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Jilin Songliao Pharmaceutical Co.,Ltd.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Shaanxi Momede Qixuehe Pharmaceutical Co.,Ltd.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Gansu Zhongtian Jindan Pharmaceutical Co.,Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Liaoning Chaohua Pharmaceutical Co.,Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Guangdong Jiatai Pharmaceutical Co.,Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Gannan Tibetan Medicine Pharmaceutical Co.,Ltd.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Chongqing Tianzhi Pharmaceutical Co.,Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Jilin Tiantai Pharmaceutical Co.,Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Liaoning Hancaotang Chinese Medicine Co.,Ltd.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Chengde Xinaimin Pharmaceutical Co.,Ltd.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Shenyang Hongyao Group Co.,Ltd.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Gansu Taikang Pharmaceutical Co.,Ltd.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Yunnan Baiyao Group Co.,Ltd.

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Lanzhou Foci Pharmaceutical Co.,Ltd.

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Guangshengyuan Chinese Medicine Co.,Ltd.

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Gansu Foren Pharmaceutical Technology Co.,Ltd.

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Langzhi Group Shuangren Pharmaceutical Co.,Ltd.

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market

Figure 4: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market: Drivers

Figure 5: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market: Challenges

Figure 6: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market: Trends

Figure 7: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market: Opportunity

Figure 8: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market: Restraint

Figure 9: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Value (USD Million) By Region

Figure 15: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Value (USD Million) By Region

Figure 23: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Ginseng, Poria and Atractylodes Macrocephala Powder Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Ginseng, Poria and Atractylodes Macrocephala Powder Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Ginseng, Poria and Atractylodes Macrocephala Powder Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Value (USD Million) By Region

Table 10: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Ginseng, Poria and Atractylodes Macrocephala Powder Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Heilongjiang Longgui Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 31: Heilongjiang Longgui Pharmaceutical Co.,Ltd.. Products Portfolio

Table 32: Chengde Tianyuan Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 33: Chengde Tianyuan Pharmaceutical Co.,Ltd.. Products Portfolio

Table 34: Jilin Songliao Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 35: Jilin Songliao Pharmaceutical Co.,Ltd.. Products Portfolio

Table 36: Shaanxi Momede Qixuehe Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 37: Shaanxi Momede Qixuehe Pharmaceutical Co.,Ltd.. Products Portfolio

Table 38: Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 39: Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd.. Products Portfolio

Table 40: Gansu Zhongtian Jindan Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 41: Gansu Zhongtian Jindan Pharmaceutical Co.,Ltd.. Products Portfolio

Table 42: Liaoning Chaohua Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 43: Liaoning Chaohua Pharmaceutical Co.,Ltd.. Products Portfolio

Table 44: Guangdong Jiatai Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 45: Guangdong Jiatai Pharmaceutical Co.,Ltd.. Products Portfolio

Table 46: Gannan Tibetan Medicine Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 47: Gannan Tibetan Medicine Pharmaceutical Co.,Ltd.. Products Portfolio

Table 48: Chongqing Tianzhi Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 49: Chongqing Tianzhi Pharmaceutical Co.,Ltd.. Products Portfolio

Table 50: Jilin Tiantai Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 51: Jilin Tiantai Pharmaceutical Co.,Ltd.. Products Portfolio

Table 52: Liaoning Hancaotang Chinese Medicine Co.,Ltd. Basic Information And Sales Area

Table 53: Liaoning Hancaotang Chinese Medicine Co.,Ltd.. Products Portfolio

Table 54: Chengde Xinaimin Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 55: Chengde Xinaimin Pharmaceutical Co.,Ltd.. Products Portfolio

Table 56: Shenyang Hongyao Group Co.,Ltd. Basic Information And Sales Area

Table 57: Shenyang Hongyao Group Co.,Ltd.. Products Portfolio

Table 58: Gansu Taikang Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 59: Gansu Taikang Pharmaceutical Co.,Ltd.. Products Portfolio

Table 60: Yunnan Baiyao Group Co.,Ltd. Basic Information And Sales Area

Table 61: Yunnan Baiyao Group Co.,Ltd.. Products Portfolio

Table 62: Lanzhou Foci Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 63: Lanzhou Foci Pharmaceutical Co.,Ltd.. Products Portfolio

Table 64: Guangshengyuan Chinese Medicine Co.,Ltd. Basic Information And Sales Area

Table 65: Guangshengyuan Chinese Medicine Co.,Ltd.. Products Portfolio

Table 66: Gansu Foren Pharmaceutical Technology Co.,Ltd. Basic Information And Sales Area

Table 67: Gansu Foren Pharmaceutical Technology Co.,Ltd.. Products Portfolio

Table 68: Langzhi Group Shuangren Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 69: Langzhi Group Shuangren Pharmaceutical Co.,Ltd.. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Value (USD Million) By Region

Table 75: Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Ginseng, Poria and Atractylodes Macrocephala Powder Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	50.40 million
Revenue forecast in 2033	87.90 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Heilongjiang Longgui Pharmaceutical Co.,Ltd.; Chengde Tianyuan Pharmaceutical Co.,Ltd.; Jilin Songliao Pharmaceutical Co.,Ltd.; Shaanxi Momede Qixuehe Pharmaceutical Co.,Ltd.; Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd.; Gansu Zhongtian Jindan Pharmaceutical Co.,Ltd.; Liaoning Chaohua Pharmaceutical Co.,Ltd.; Guangdong Jiatai Pharmaceutical Co.,Ltd.; Gannan Tibetan Medicine Pharmaceutical Co.,Ltd.; Chongqing Tianzhi Pharmaceutical Co.,Ltd.; Jilin Tiantai Pharmaceutical Co.,Ltd.; Liaoning Hancaotang Chinese Medicine Co.,Ltd.; Chengde Xinaimin Pharmaceutical Co.,Ltd.; Shenyang Hongyao Group Co.,Ltd.; Gansu Taikang Pharmaceutical Co.,Ltd.; Yunnan Baiyao Group Co.,Ltd.; Lanzhou Foci Pharmaceutical Co.,Ltd.; Guangshengyuan Chinese Medicine Co.,Ltd.; Gansu Foren Pharmaceutical Technology Co.,Ltd.; Langzhi Group Shuangren Pharmaceutical Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Limited availability of high-quality raw materials, such as ginseng and atractylodes macrocephala, may restrain market growth due to supply chain disruptions and price fluctuations.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Ginseng, Poria and Atractylodes Macrocephala Powder Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

12g

Regional Insights

Loading chart…

Competitive Landscape

Heilongjiang Longgui Pharmaceutical Co.,Ltd. - regional expansion

Chengde Tianyuan Pharmaceutical Co.,Ltd. - vertical integration

Jilin Songliao Pharmaceutical Co.,Ltd. - premium pricing

Shaanxi Momede Qixuehe Pharmaceutical Co.,Ltd. - OEM tie-ups

Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd. - innovation pipeline

Gansu Zhongtian Jindan Pharmaceutical Co.,Ltd. - local manufacturing

Key Ginseng, Poria and Atractylodes Macrocephala Powder Companies20 items

Heilongjiang Longgui Pharmaceutical Co.,Ltd.

Chengde Tianyuan Pharmaceutical Co.,Ltd.

Jilin Songliao Pharmaceutical Co.,Ltd.

Shaanxi Momede Qixuehe Pharmaceutical Co.,Ltd.

Chengdu Jiuzhitang Jinding Pharmaceutical Co.,Ltd.

Gansu Zhongtian Jindan Pharmaceutical Co.,Ltd.

Liaoning Chaohua Pharmaceutical Co.,Ltd.

Guangdong Jiatai Pharmaceutical Co.,Ltd.

Gannan Tibetan Medicine Pharmaceutical Co.,Ltd.

Chongqing Tianzhi Pharmaceutical Co.,Ltd.

Jilin Tiantai Pharmaceutical Co.,Ltd.

Liaoning Hancaotang Chinese Medicine Co.,Ltd.

Chengde Xinaimin Pharmaceutical Co.,Ltd.

Shenyang Hongyao Group Co.,Ltd.

Gansu Taikang Pharmaceutical Co.,Ltd.

Yunnan Baiyao Group Co.,Ltd.

Lanzhou Foci Pharmaceutical Co.,Ltd.

Guangshengyuan Chinese Medicine Co.,Ltd.

Gansu Foren Pharmaceutical Technology Co.,Ltd.

Langzhi Group Shuangren Pharmaceutical Co.,Ltd.

Market Ecosystem

Raw material/component suppliers — provide raw materials

OEMs / manufacturers — produce powder products

Distributors / channel partners — manage logistics and distribution

Regulators/standards bodies — establish quality and safety standards

End users / buyers — purchase and consume the powder products

Technology providers — develop processing and manufacturing technologies

Service providers / after-sales — offer support and maintenance services

Recent Industry Insights

Analyst Overview

Table of Contents